Article
Dynamics of Leukemic Blast and Immune Cell Populations in Acute Myeloid Leukemia
2026-03-24
Abstract excerpt
Most patients with acute myeloid leukemia (AML) initially respond to standard chemotherapy. However, relapse and refractory disease remain common. The responses to targeted therapies are often transient and the efficacy of immunotherapy is limited. Although single-cell RNA sequencing (scRNA-seq) studies have provided insights into the cellular diversity and immune landscape of AML, many have primarily focused on l...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 26512e36-35cc-5070-9b7c-439f583d9352
- DOI
- 10.64898/2026.03.21.713278
